PHAT - Phathom Pharmaceuticals GAAP EPS of -$1.33 misses by $0.30 August, 02 2022 08:41 AM Phathom Pharmaceuticals Inc. Phathom Pharmaceuticals press release ( NASDAQ: PHAT ): Q2 GAAP EPS of -$1.33 misses by $0.30 . Net loss for the Q2 2022 was $50.9M. For further details see: Phathom Pharmaceuticals GAAP EPS of -$1.33 misses by $0.30